IspE kinase as an anti-infective target: Role of a hydrophobic pocket in inhibitor binding

Rawia Hamid1, Danica J Walsh2, Eleonora Diamanti2

  • 1Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) - Helmholtz Centre for Infection Research (HZI), Campus Building E8.1, 66123 Saarbrücken, Germany; Department of Pharmacy, Saarland University, 66123 Saarbrücken, Germany.

PubMed

Insights

Researchers explored the methylerythritol phosphate (MEP) pathway enzyme IspE as a target for new antimicrobial drugs. Structural studies reveal unique features in bacterial IspE, guiding the design of selective inhibitors against pathogens.

Area of Science:

  • Biochemistry
  • Structural Biology
  • Drug Discovery

Background:

  • The methylerythritol phosphate (MEP) pathway is crucial for microbial survival and a promising target for antimicrobial drug development.
  • IspE kinase, a key enzyme in the MEP pathway, is investigated for its potential as an antimicrobial target.

Purpose of the Study:

  • To investigate the IspE kinase from pathogenic bacteria (Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii) using biochemical and structural methods.
  • To understand the structural basis for inhibitor binding to IspE homologs and identify strategies for selective inhibition.

Main Methods:

  • X-ray crystallography was used to determine the structures of IspE-inhibitor complexes.
  • Biochemical assays were employed to study inhibitor binding modes and efficacy.

Main Results:

  • Distinct structural features were identified among IspE homologs from different pathogenic bacteria.
  • A. baumannii IspE possesses a unique hydrophobic subpocket, influencing its inhibitory profile.
  • Structure-based insights into inhibitor interactions with the IspE substrate pocket were obtained.

Conclusions:

  • Structural variations in IspE necessitate tailored inhibitor strategies for effective antimicrobial drug design.
  • This research provides a foundation for developing novel, structure-based inhibitors targeting pathogenic bacterial MEP pathways.
  • Targeting bacterial IspE offers a potential avenue for combating drug-resistant infections.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.7K
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
8.5K
Protein-protein Interfaces02:04

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.3K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.1K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K